INmune Bio extends shareholder rights plan expiration to December 30, 2024

Inmune Bio, Inc.

Entered Amendment No. 3 to Rights Agreement, extending expiration from Dec 30, 2023 to Dec 30, 2024.
Amendment No. 3 also updated notice provisions in the Rights Agreement.
The rights plan was originally adopted in December 2020 and previously extended twice.
No other substantive changes to the rights or terms of the agreement.

item 1.01 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Inmune Bio, Inc. amended Amendment No. 3 to the Rights Agreement with VStock Transfer, LLC (effective 2023-12-14).

Action: amendment
Counterparty: VStock Transfer, LLC
Effective: 2023-12-14

Exact text from the filing

On December 14, 2023, the Company and VStock Transfer, LLC entered into Amendment No. 3 to the Rights Agreement ("Amendment No. 3").

View on SEC.gov

Browse all material agreements →

Inmune Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-096477

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.